Solubility and Scale-Up Potency of Norfloxacin-Urea Co-Crystal Prepared by Ultrasound-Assisted Slurry Co-Crystallization Method

Authors

DOI:

https://doi.org/10.33084/bjop.v6i2.4173

Keywords:

Norfloxacin, Urea, Co-crystal, Ultrasound-assisted slurry co-crystalllization, Solubility

Abstract

Norfloxacin is an antimicrobial in treating urinary tract infections with low water solubility. This study aims to know the effect of norfloxacin-urea co-crystal formation on the solubility of norfloxacin and the potential for scale-up when prepared by ultrasound-assisted slurry co-crystallization method. Identification of the screening result of the norfloxacin-urea (1 : 1) co-crystal formation by a wet grinding method using an ethanol-acetone (1 : 1) solvent mixture was performed by powder X-ray diffractometer (PXRD). The ultrasound-assisted slurry co-crystallization method was used for co-crystal formation with five-fold the weight of norfloxacin and urea than the wet grinding method. The co-crystal product prepared by the ultrasound-assisted slurry co-crystallization method was observed for its crystal morphology and characterized by PXRD and differential scanning calorimeter (DSC). Solubility and dissolution tests in water and acetate buffer solution pH 4.0 were used to evaluate the physicochemical properties. Identification of co-crystal screening by PXRD revealed the formation of norfloxacin-urea co-crystal. The PXRD pattern of the norfloxacin-urea co-crystal product prepared by the ultrasound-assisted slurry co-crystallization method was similar to the wet grinding method. Norfloxacin-urea co-crystal has a different melting point and crystal morphology from pure norfloxacin and urea. The solubility and dissolution rate of norfloxacin-urea co-crystal was higher in water and not significantly different in acetate buffer solution pH 4.0 compared to pure norfloxacin. This study showed that the norfloxacin-urea co-crystal formation could enhance the solubility of norfloxacin in water and had the potential for scale-up when prepared using the ultrasound-assisted slurry co-crystallization method.

Views: 604Downloads: 539

Downloads

Download data is not yet available.

Author Biographies

References

Gadade DD, Sarda K, Shahi SR. Investigation and optimization of the effect of polymers on drug release of norfloxacin from floating tablets. Polim Med. 2016;46(2):117–27. doi:10.17219/pim/68170

Vijan LE, Conci M. Absorption study of norfloxacin - DNA interaction. Macromol Symp. 2008;265(1):260–7. doi:10.1002/masy.200850529

Ferreira PO, de Almeida AC, dos Santos ÉC, Droppa R, Ferreira FF, Kogawa AC, et al. A norfloxacin-nicotinic acid cocrystal: Mechanochemical synthesis, thermal and structural characterization and solubility assays. Thermochim Acta. 2020;694:178782. doi:10.1016/j.tca.2020.178782

Fael H, Barbas R, Prohens R, Rafols C, Fuguet E. Synthesis and characterization of a new norfloxacin/resorcinol cocrystal with enhanced solubility and dissolution profile. Pharmaceutics. 2022;14(1):49. doi:10.3390/pharmaceutics14010049

Basavoju S, Bostrom D, Velaga P. Pharmaceutical cocrystals and salts of norfloxacin. Cryst Growth Des. 2006;6(12):2699–708. doi:10.1021/cg060327x

Thayyil AR, Juturu T, Nayak S, Kamath S. Pharmaceutical co-crystallization: Regulatory aspects, design, characterization, and applications. Adv Pharm Bull. 2020;10(2):203–12. doi:10.34172/apb.2020.024

Guo M, Sun X, Chen J, Cai T. Pharmaceutical cocrystals: A review of preparations, physicochemical properties and applications. Acta Pharm Sin B. 2021;11(8):2537–64. doi:10.1016/j.apsb.2021.03.030

Erxleben A. Cocrystal applications in drug delivery. Pharmaceutics. 2020;12(9):834–6. doi:10.3390/pharmaceutics12090834

Alatas F, Ratih H, Kurnia H, Soewandhi SN. Solubility enhancement of clozapine through co-crystal formation with isonicotinamide. Indones J Pharm. 2019;2(1):1–6. doi:10.24198/idjp.v2i1.23957

Ross SA, Hurt AP, Antonijevic M, Bouropoulos N, Ward A, Basford P, et al. Continuous manufacture and scale-up of theophylline- nicotinamide cocrystals. Pharmaceutics. 2021;13(3):419. doi:10.3390/pharmaceutics13030419

am Ende DJ, Anderson SR, Salan JS. Development and scale-up of cocrystals using resonant acoustic mixing. Org Process Res Dev. 2014;18(2):331–41. doi:10.1021/op4003399

Karimi-Jafari M, Padrela L, Walker GM, Croker DM. Creating cocrystals : A review of pharmaceutical cocrystal preparation routes and applications. Cryst Growth Des. 2018;18(10):6370–87. doi:10.1021/acs.cgd.8b00933

Pawar N, Saha A, Nandan N, Parambil J V. Solution cocrystallization: a scalable approach for cocrystal production. Crystals. 2021;11(3):303. doi:10.3390/cryst11030303

Apshingekar PP, Aher S, Kelly AL, Brown EC, Paradkar A. Synthesis of caffeine/maleic acid co-crystal by ultrasound-assisted slurry co-crystallization. J Pharm Sci. 2017;106(1):66–70. doi:10.1016/j.xphs.2016.09.009

Friscic T, Childs SL, Rizvi SAA, Jones W. The role of solvent in mechanochemical and sonochemical cocrystal formation : a solubility-based approach for predicting cocrystallisation outcome. Cryst Eng Comm. 2009;11(3):418–26. doi:10.1039/b815174a

Song JX, Yan Y, Yao J, Chen JM, Lu TB. Improving the Solubility of Lenalidomide via Cocrystals. Cryst Growth Des. 2014;14(6):3069–77. doi:10.1021/cg500327s

Allu S, Bolla G, Tothadi S, Nangia AK. Novel pharmaceutical cocrystals and salts of bumetanide. Cryst Growth Des. 2020;20(2):793–803. doi:10.1021/acs.cgd.9b01195

Leng F, Robeyns K. Urea as a cocrystal former — Study of 3 urea based pharmaceutical cocrystals. Pharmaceutics. 2021;13(5):671. doi:10.3390/pharmaceutics13050671

Maddileti D, Jayabun SK, Nangia A. Soluble cocrystals of the xanthine oxidase inhibitor febuxostat. Cryst Growth Des. 2013;13(7):3188–96. doi:10.1021/cg400583z

Yamamoto K, Tsutsumi S, Ikeda Y. Establishment of cocrystal cocktail grinding method for rational screening of pharmaceutical cocrystals. Int J Pharm. 2012;437(1–2):162–71. doi:10.1016/j.ijpharm.2012.07.038

Haskins MM, Zaworotko MJ. Screening and preparation of cocrystals: A comparative study of mechanochemistry vs slurry methods. Cryst Growth Des. 2021;21(7):4141–50. doi:10.1021/acs.cgd.1c00418

de Campos DP, Silva-Barcellos NM, Lima RR, Savedra RML, Siqueira MF, Yoshida MI, et al. Polymorphic and quantum chemistry characterization of candesartan cilexetil: importance for the correct drug classification According to Biopharmaceutics Classification System. AAPS PharmSciTech. 2018;19(7):3019–28. doi:10.1208/s12249-018-1129-6

Convention USP. USP 29, NF 24: The United States Pharmacopeia, the National Formulary. Rockville, MD: United States Pharmacopeial Convention; 2006. p. 1560.

Miroshnyk I, Mirza S, Sandler N. Pharmaceutical co-crystals-an opportunity for drug product enhancement. Expert Opin Drug Deliv. 2009;6(4):333–41. doi:10.1517/17425240902828304

Hasa D, Jones W. Screening for new pharmaceutical solid forms using mechanochemistry: A practical guide. Adv Drug Deliv Rev. 2017;117:147–61. doi:10.1016/j.addr.2017.05.001

Alatas F, Ratih H, Sutarna TH, Wardhana YW, Tereslina D, Soewandhi SN. Preparation and characterization of fluconazole-resorcinol co-crystal. J Ilmu Kefarmasian Indones. 2020;18(2):177–83. doi:10.35814/jifi.v18i2.779

House KA, House JE. Thermodynamics of dissolution of urea in water, alcohols, and their mixtures. J Mol Liq. 2017;242:428–32. doi:10.1016/j.molliq.2017.07.020

Zhang CL, Li BY, Wang Y. Solubilities of norfloxacin in ethanol, 1-propanol, acetone, and chloroform from 294.15 to 318.15k. Can J Chem Eng. 2010;88(1):63–6. doi:10.1002/cjce.20247

Mukaida M, Watanabe Y, Sugano K, Terada K. Identification and physicochemical characterization of caffeine–citric acid co-crystal polymorphs. Pharm Sci. 2015;79:61–6. doi:10.1016/j.ejps.2015.09.002

El-Gizawy SA, Osman MA, Arafa MF, El Maghraby GM. Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide. Int J Pharm. 2015;478(2):773–8. doi:10.1016/j.ijpharm.2014.12.037

Aher S, Dhumal R, Mahadik K, Paradkar A, York P. Ultrasound assisted cocrystallization from solution (USSC) containing a non-congruently soluble cocrystal component pair: Caffeine/maleic acid. Eur J Pharm Sci. 2010;41(5):597–602. doi:10.1016/j.ejps.2010.08.012

Klisurića OR, Rakića SJ, Cvetinov MJ, Stojanović MM, Nikolić AR, Santa SSJ, et al. X-ray diffraction characterization of different polymorphyc forms of clopidogrel bisulphate in substance and pharmaceutical dosage form. J Res Phys. 2013;37(1):55–60. doi:10.2478/jrp-2013-0006

Paczkowska M, Wiergowska G, Miklaszewski A, Krause A, Mroczkowka M, Zalewski P, et al. The analysis of the physicochemical properties of benzocaine polymorphs. Molecules. 2018;23(7):1737. doi:10.3390/molecules23071737

Barbas R, Martí F, Prohens R, Puigjaner C. Polymorphism of norfloxacin: Evidence of the enantiotropic relationship between polymorphs A and B. Cryst Growth Des. 2006;6(6):1463–7. doi:10.1021/cg060101u

Bavishi DD, Borkhataria CH. Spring and parachute: How cocrystals enhance solubility. Prog Cryst Growth Charact Mater. 2016;62(3):1–8. doi:10.1016/j.pcrysgrow.2016.07.001

Ahumada AA, Seeck J, Allemandi D, Manzo RH. The pH/solubility profile of norfloxacin. STP Pharm Sci. 1993;3(3):250–3.

Downloads

Published

05/31/2023

How to Cite

1.
Alatas F, Stiawan D, Al-Hakim NA. Solubility and Scale-Up Potency of Norfloxacin-Urea Co-Crystal Prepared by Ultrasound-Assisted Slurry Co-Crystallization Method. Borneo J Pharm [Internet]. 2023 May 31 [cited 2026 Nov. 18];6(2):158-67. Available from: https://journal.umpr.ac.id/index.php/bjop/article/view/4173

Similar Articles

31-40 of 47

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)